Repository logo
 

Disagreement in risk groups for metastatic renal cancer.

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Abstract

In patients with metastatic renal cell carcinoma, risk stratification according to the Memorial Sloan Kettering Cancer Center or the International Metastatic Renal Cell Carcinoma Database Consortium classification systems is a crucial part of clinical assessment and essential for guiding management. New research has now demonstrated that disagreement in risk-group classification is common and prognostically relevant.

Description

Journal Title

Nat Rev Urol

Conference Name

Journal ISSN

1759-4812
1759-4820

Volume Title

16

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://www.rioxx.net/licenses/all-rights-reserved